The class of 2004: Human capital in biotechnology

David Collingham

DOI:https://doi.org/10.5912/jcb89

Abstract:

This paper assesses growth models for biotechnology organisations, comparing the dynamics of company evolution in the previous decade with circumstances pertinent to the more recent market downturn and financial constraints. Using anecdotal evidence gained from senior executives in biotechnology companies in the USA, Australia and Europe, the author demonstrates how the utilisation of human talent has evolved over the past decade. The creative use of human capital for companies with limited financial means is discussed, in the context of the differing needs of organisations as they progress along the biotechnology life cycle.

Keywords:FIDCO ,SME ,non-executive director ,interim management ,serial entrepreneur ,virtual organisation ,CEO ,en ,